Growth Metrics

Pacira BioSciences (PCRX) Shares Repurchased (2025)

Pacira BioSciences has reported Shares Repurchased over the past 1 years, most recently at $48.2 million for Q4 2025.

  • Quarterly results put Shares Repurchased at $48.2 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $98.3 million (changed N/A YoY), and the annual figure for FY2025 was $148.3 million, up 493.31%.
  • Shares Repurchased for Q4 2025 was $48.2 million at Pacira BioSciences, down from $50.0 million in the prior quarter.
  • Over the last five years, Shares Repurchased for PCRX hit a ceiling of $50.0 million in Q3 2025 and a floor of $48.2 million in Q4 2025.